Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners

Clinical Linguistics and Phonetics

Volumn 21, Issue 10, 2007, Pages 783-791

  De Letter, Miet ^a   Santens, Patrick ^a   Estercam, Irina ^a   Van Maele, Georges ^a   De Bodt, Marc ^b   Boon, Paul ^a   Van Borsel, John ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Comprehensibility; Dysarthria; Levodopa; Loudness; Parkinson; Pitch; Prosody; Speech rate; Variability

Indexed keywords

AMANTADINE; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPREHENSION; CONTROLLED STUDY; DRUG USE; DYSARTHRIA; FEMALE; HUMAN; LOUDNESS; MALE; OUTCOME ASSESSMENT; PARKINSON DISEASE; PITCH; PRIORITY JOURNAL; READING; SPEECH ANALYSIS; SPEECH RATE; TASK PERFORMANCE;

AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; DRUG THERAPY, COMBINATION; DYSARTHRIA; FEMALE; HUMANS; LEVODOPA; LINGUISTICS; MALE; MIDDLE AGED; PARKINSON DISEASE; PERGOLIDE; SOUND SPECTROGRAPHY; SPEECH ACOUSTICS; SPEECH INTELLIGIBILITY; SPEECH PRODUCTION MEASUREMENT; VERBAL BEHAVIOR;

EID: 34748816871     PISSN: 02699206     EISSN: 14645076     Source Type: Journal    
DOI: 10.1080/02699200701538181     Document Type: Article

References (38)

1. Adelman, J. U., Hoel, R. L. and Lassman, M. E. (1970) The effect of L-DOPA treatment on speech of patients with Parkinson's disease. Neurology, 20, pp. 410-411.
2. Bunton, K., Kent, R. D., Kent, J. F. and Rosenbek, J. C. (2000) Perceptuo-acoustic assessment of prosodic impairment in dysarthria. Clinical Linguistics and Phonetics, 14, pp. 13-24.
3. Bunton, K., Kent, R. D., Kent, J. F. and Duffy, J. R. (2001) The effects of flattening fundamental frequency contours on sentence intelligibility in speakers with dysarthria. Clinical Linguistics and Phonetics, 15, pp. 181-193.
4. Canter, G. (1965) Speech characteristics in patients with Parkinson's disease: II Physiological support for speech. Journal of Speech and Hearing Disorders, 30, pp. 44-49.
5. Dagenais, P. A., Brown, G. R. and Moore, R. E. (2006) Speech rate effects upon intelligibility and acceptability of dysarthric speech. Clinical Linguistics and Phonetics, 20, pp. 141-148.
6. Darley, F. L., Aronson, A. E. and Brown, J. R. (1969) Differential diagnostic patterns of dysarthria. Journal of Speech and Hearing Research, 1, pp. 246-269.
7. Darley, F. L., Aronson, A. E. and Brown, J. R. (1975) Motor Speech Disorders, WB Saunders, Philadelphia, PA
8. Defer, G. L., Widner, H., Marie, R. M., Remy, P. and Levivier, M. (1999) Core assessment programme for surgical intervention therapies in Parkinson's disease (CAPSIT-PD). Movement Disorders, 14, pp. 572-584.
9. De Letter, M., Santens, P. and Van Borsel, J. (2005) The effects of levodopa on word intelligibility in Parkinson's disease. Journal of Communication Disorders, 38, pp. 187-196.
10. De Letter, M., Santens, P., De Bodt, M., Boon, P. and Van Borsel, J. (2006) Levodopa-induced alterations in speech rate in advanced Parkinson's disease. Acta Neurologica Belgica, 106, pp. 19-22.
11. Duffy, J. R. (1995) Hypokinetic dysarthria. Motor Speech Disorders: substrates, differential diagnosis and management, pp. 166-188. Mosby, St. Louis, MI
12. Fahn, S., Elton, R. L. and members of the UPDRS Development Committee (1987) Unified Parkinson Disease Rating Scale. Recent developments in Parkinson's disease, 2, pp. 153-163. Macmillan Healthcare Information, Florha Park, NJ
13. Flint, A., Black, S., Campbell-Taylor, I., Gailey, G. and Levinton, C. (1992) Acoustic analysis in the differentiation between Parkinson's Disease and major depression. Journal of Psycholinguistic Research, 21, pp. 383-399.
14. Gelb, D. J., Oliver, E. and Gilman, S. (1999) Diagnostic criteria for Parkinson Disease. Archives of Neurology, 56, pp. 33-39.
15. German Parkinson Study Group, Neurostimulation Section (2006) A randomized Trial of Deep-Brain Stimulation for Parkinson's Disease. The New England Journal of Medicin, 355, pp. 896-908.
16. Goberman, A., Coelho, C. and Robb, M. (2005) Prosodic characteristics of Parkinsonian speech: The effect of levodopa-based medication. Journal of Medical Speech-Language Pathology, 13, pp. 51-68.
17. Goberman, A. M. and Elmer, L. W. (2005) Acoustic analysis of clear versus conversational speech in individuals with Parkinson disease. Journal of Communication Disorders, 38, pp. 215-230.
18. Ho, A. K., Bradshaw, J. L., Iansek, R. and Alfredson, R. (1999) Speech volume regulation in Parkinson's disease: Effects of implicit cues and explicit instructions. Neuropsychologia, 37, pp. 1453-1460.
19. Hoehn, M. M. and Yahr, M. D. (1967) Parkinsonism: Onset, progression and mortality. Neurology, 17, pp. 427-442.
20. International Phonetic Association (1974) (1974) The principles of the International Phonetic Association.,.
21. Kompoliti, K., Wang, Q. E., Goetz, C. G., Leurgans, S. and Raman, R. (2000) Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease. Neurology, 25, pp. 458-462.
22. Lannoo, E. and Vingerhoets, G. (1997) Flemish normative data on common neuropsychological tests: Influence of age, education and gender. Psychologica Belgica, 37, pp. 141-155.
23. Lloyd, A. J. (1999) Comprehension of prosody in Parkinson's disease. Cortex, 35, pp. 389-402.
24. Ludlow, C., Connor, N. and Bassich, C. (1987) Speech timing in Parkinson's and Huntington's Disease. Brain and Language, 32, pp. 195-214.
25. McNamara, P. and Durso, R. (2003) Pragmatic communication skills in patients with Parkinson's disease. Brain and Language, 84, pp. 414-423.
26. Metter, E. J. (1985) Speech disorders: Clinical Evaluation and Diagnosis, Spectrum Publications, New York
27. Metter, E. J. and Hanson, W. R. (1986) Clinical and acoustical variability in hypokinetic dysarthria. Journal of Communication Disorders, 19, pp. 347-366.
28. Molloy, S. A., Rowan, E. N., O'Brien, J. T., McKeith, I. G., Wesnes, K. and Burn, D. J. (2006) Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies. Journal of Neurology, Neurosurgery and Neuropsychiatry, 77, pp. 1323-1328.
29. Nakano, K. K., Zubick, H. and Tyler, H. R. (1973) Speech defects of parkinsonian patients: Effects of levodopa therapy on speech intelligibility. Neurology, 23, pp. 865-870.
30. Pell, M. D., Cheang, H. S. and Leonard, C. L. (2006) The impact of Parkinson's disease on vocal-prosodic communication from the perspectives of listeners. Brain and Language, 97, pp. 123-134.
31. Pitcairn, T. K., Clemie, S., Gray, J. M. and Pentland, B. (1990) Impressions of parkinsonian patients from their recorded voices. British Journal of Disorders of Communication, 25, pp. 85-92.
32. Santens, P., De Letter, M., Van Borsel, J., De Reuck, J. and Caemaert, J. (2003) Lateralized effects of subthalamic nucleus stimulation on different aspects of speech in Parkinson's disease. Brain and language, 87, pp. 253-258.
33. Scientific Advisory Committee of the Medical Outcomes Trust (2002) Assessing health status and quality-of-life instruments: Attributes and review criteria. Quality of Life Research, 11, pp. 193-205.
34. Solomon, N. P. and Hixon, T. J. (1993) Speech Breathing in Parkinson's Disease. Journal of Speech and Hearing Research, 36, pp. 294-310.
35. Tjaden, K. A. (2000) Preliminary study of factors influencing perception of articulatory rate in Parkinson's disease. Journal of Speech, Language, and Hearing Research, 43, pp. 997-1010.
36. Tjaden, K. and Wilding, G. E. (2004) Rate and loudness manipulations in dysarthria: Acoustic and perceptual findings. Journal of Speech, Language and Hearing Research, 47, pp. 766-783.
37. Vingerhoets, G., Verleden, S., Santens, P., Miatton, M. and De Reuck, J. (2003) Predictors of cognitive impairment in advanced Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 74, pp. 793-796.
38. Wolfe, V. I., Garvin, J. S., Bacon, M. and Waldrop, W. (1975) Speech changes in Parkinson's disease during treatment with L-dopa. Journal of Communication Disorders, 8, pp. 271-279.